Linden M D, Ma C K, Kubus J, Brown R D, Zarbo R J
Department of Pathology, Henry Ford Hospital, Detroit, MI 48202.
Am J Clin Pathol. 1993 Sep;100(3):206-12. doi: 10.1093/ajcp/100.3.206.
The prognostic significance of tumor proliferative activity (TPA) in colorectal adenocarcinomas (CA) determined by proliferating cell nuclear antigen (PCNA) and Ki-67 staining is not well defined. Previous investigations of TPA using Ki-67 immunohistologic studies and flow cytometric (FCM) analysis have found no correlation with conventional histopathologic parameters. To better define the relationship of these various TPA measurements in CA, the authors selected 46 tumors with diploid DNA content previously analyzed by two-color DNA FCM analysis of fresh specimens to more effectively assess actual S-phase fractions (SPFs) from cytokeratin-gated DNA histograms for comparison with the following: (1) immunohistologic Ki-67 and PCNA tumor proliferation indices (TPIs); and (2) conventional histopathologic observations of prognostic import. These data show no significant correlation coefficient between Ki-67 or PCNA TPIs and SPFs derived from FCM analysis; however, the DNA diploid tumor subset categorized as having a greater than median SPF value had a significantly higher mean Ki-67 but not PCNA proliferation index. There was no correlation of any measure of proliferation with any of the eight histopathologic features of known prognostic significance.
通过增殖细胞核抗原(PCNA)和Ki-67染色测定的肿瘤增殖活性(TPA)在结肠腺癌(CA)中的预后意义尚未明确界定。先前使用Ki-67免疫组织学研究和流式细胞术(FCM)分析对TPA进行的研究发现,其与传统组织病理学参数无关。为了更好地界定CA中这些不同TPA测量值之间的关系,作者选择了46例具有二倍体DNA含量的肿瘤,这些肿瘤之前已通过新鲜标本的双色DNA FCM分析进行过分析,以便更有效地从细胞角蛋白门控DNA直方图中评估实际的S期分数(SPF),并与以下内容进行比较:(1)免疫组织学Ki-67和PCNA肿瘤增殖指数(TPI);(2)具有预后意义的传统组织病理学观察结果。这些数据显示,Ki-67或PCNA TPI与FCM分析得出的SPF之间无显著相关系数;然而,DNA二倍体肿瘤亚组中SPF值大于中位数的亚组,其平均Ki-67增殖指数显著更高,但PCNA增殖指数并非如此。任何增殖指标与已知具有预后意义的八个组织病理学特征中的任何一个均无相关性。